NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
11/17/2025
Back to search
Official data from USPTO
ADVENT ADVANCES IN TYPE 2 IMMUNE DISEASES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
11/18/2025
Trademark type
Combined
Nice classes
41
Filing date
10/06/2017
Registration date
02/19/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/17/2025
Last transaction
11/18/2025
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
03
Owner location
Gentilly, FR
Examiner
RINKER,ANTHONY MICHAEL
Current location
Historical data usage
Mark description
The mark consists of the stylized wording "ADVENT" below two slightly offset chevrons facing the opposite direction. The stylized wording "ADVANCES IN TYPE 2 IMMUNE DISEASES" appears below the wording "ADVENT".
Holders and representatives
Holders
S. B. (pessoa física)
S. B. (pessoa física)
Representatives
Alexandra Kochian FROSS ZELNICK LEHRMAN & ZISSU, P.C.
Technical classification
Nice Classes
Class 41
Vienna Codes
No Vienna codes available.
Goods and services
Class 41
Educational servicesarranging and conducting classesseminarsconferencesworkshops for patients with immune system related diseases and disordersasthmaatopic dermatitisnasal polyposisin the fields of immunology and inflammatory diseases
Publications
History of USPTO decisions and trademark events.
34 publications found
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
11/17/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/08/2025
ES8R
TEAS SECTION 8 RECEIVED
07/10/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
02/19/2024
CORV
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
01/08/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/10/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
02/19/2019
TMBN
TTAB RELEASE CASE TO TRADEMARKS
01/11/2019
OP.T
OPPOSITION TERMINATED NO. 999999
01/11/2019
OP.D
OPPOSITION DISMISSED NO. 999999
01/11/2019
OP.I
OPPOSITION INSTITUTED NO. 999999
05/23/2018
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
04/26/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/27/2018
PUBO
PUBLISHED FOR OPPOSITION
03/27/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/07/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/16/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/16/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/16/2018
ALIE
ASSIGNED TO LIE
02/11/2018
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/01/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/25/2018
GNSL
LETTER OF SUSPENSION E-MAILED
01/25/2018
CNSL
SUSPENSION LETTER WRITTEN
01/25/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/24/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/23/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/23/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/09/2017
GNRT
NON-FINAL ACTION E-MAILED
12/09/2017
CNRT
NON-FINAL ACTION WRITTEN
12/09/2017
DOCK
ASSIGNED TO EXAMINER
11/30/2017
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
10/14/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/13/2017
NWAP
NEW APPLICATION ENTERED
10/10/2017
Continuous trademark protection
Get notified about every new filing that threatens ADVENT ADVANCES IN TYPE 2 IMMUNE DISEASES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.